Elekta included in Dow Jones Sustainability Index
The DJSI has included Elekta on its Dow Jones Sustainability Europe Index in the Health Care Equipment & Services group. Companies included in the DJSI are assessed according to certain economic, environmental and social parameters.
“We are very proud that our work is recognized for its sustainability,” says Brittmarie Djurle, Elekta’s Global Vice President, Corporate Social Responsibility & Risk Management. “That we have been included in the index encourages us to continue our efforts and become even better.”
The DJSI is based on an in-depth analysis of financially material economic, environmental and social practices. These include innovation or supply chain management, climate strategy and stakeholder engagement and places a special focus on industry-specific risks and opportunities.
Launched in 1999, the Dow Jones Sustainability Indices are the first global indices to track the financial performance of sustainability-driven companies worldwide.
# # #
For further information, please contact:
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: email@example.com
Time zone: CET: Central European Time
Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, e-mail: firstname.lastname@example.org
Time zone: ET: Eastern Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 13:00 CET on September 18, 2013.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.